Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3
Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3
Sponsor: The George Institute for Global Health, China
This NA trial investigates Acute Coronary Syndromes and is currently completed. The George Institute for Global Health, China leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Sep 2025 — Feb 2026 [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The George Institute for Global Health, China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Anyang, China, Baicheng, China, Baishan, China, Baoding, China, Baoji, China, Bijie, China, Bozhou, China, Buwei, China, Changzhi, China, Chaohu, China and 74 more location s